All Posts:aspirin and breast cancer

• The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity

  A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.

  Category: News Release Tags: aspirin and breast cancer, breast cancer, breast cancer research, cancer research, clinical trials